526853 Stock Overview
Provides pharmaceutical packaging research solutions in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bilcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹54.89 |
| 52 Week High | ₹95.40 |
| 52 Week Low | ₹51.00 |
| Beta | 1.17 |
| 1 Month Change | 2.01% |
| 3 Month Change | -12.90% |
| 1 Year Change | -29.57% |
| 3 Year Change | -26.81% |
| 5 Year Change | 188.14% |
| Change since IPO | -51.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526853 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -5.4% | -1.3% | -4.2% |
| 1Y | -29.6% | 49.7% | 19.1% |
Return vs Industry: 526853 underperformed the Indian Life Sciences industry which returned 49.7% over the past year.
Return vs Market: 526853 underperformed the Indian Market which returned 19.1% over the past year.
Price Volatility
| 526853 volatility | |
|---|---|
| 526853 Average Weekly Movement | 4.8% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 526853 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 526853's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 73 | n/a | www.bilcare.com |
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for packaging of solid dosage pharmaceutical products. It also offers CR, blister, and lidding foils; blister films and laminates.
Bilcare Limited Fundamentals Summary
| 526853 fundamental statistics | |
|---|---|
| Market cap | ₹1.29b |
| Earnings (TTM) | -₹401.71m |
| Revenue (TTM) | ₹7.71b |
0.2x
P/S Ratio-3.2x
P/E RatioIs 526853 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526853 income statement (TTM) | |
|---|---|
| Revenue | ₹7.71b |
| Cost of Revenue | ₹5.27b |
| Gross Profit | ₹2.44b |
| Other Expenses | ₹2.84b |
| Earnings | -₹401.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | -17.06 |
| Gross Margin | 31.64% |
| Net Profit Margin | -5.21% |
| Debt/Equity Ratio | 120.5% |
How did 526853 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 23:57 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bilcare Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |
| Ranjit Kapadia | Centrum Broking Limited |
| Hemang Tanna | Indsec Securities & Finance Ltd. |